Cargando…
CYC31, A Natural Bromophenol PTP1B Inhibitor, Activates Insulin Signaling and Improves Long Chain-Fatty Acid Oxidation in C2C12 Myotubes
3-bromo-4,5-Bis(2,3-dibromo-4,5-dihydroxybenzyl)-1,2-benzenediol (CYC31) is a bromophenol protein tyrosine phosphatase 1B (PTP1B) inhibitor isolated from the red alga Rhodomela confervoides. Here, the effect of CYC31 on the insulin signaling and fatty-acid-induced disorders in C2C12 myotubes was inv...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281472/ https://www.ncbi.nlm.nih.gov/pubmed/32438641 http://dx.doi.org/10.3390/md18050267 |
_version_ | 1783543928075583488 |
---|---|
author | Luo, Jiao Hou, Yufei Xie, Mengyue Ma, Wanli Shi, Dayong Jiang, Bo |
author_facet | Luo, Jiao Hou, Yufei Xie, Mengyue Ma, Wanli Shi, Dayong Jiang, Bo |
author_sort | Luo, Jiao |
collection | PubMed |
description | 3-bromo-4,5-Bis(2,3-dibromo-4,5-dihydroxybenzyl)-1,2-benzenediol (CYC31) is a bromophenol protein tyrosine phosphatase 1B (PTP1B) inhibitor isolated from the red alga Rhodomela confervoides. Here, the effect of CYC31 on the insulin signaling and fatty-acid-induced disorders in C2C12 myotubes was investigated. Molecular docking assay showed that CYC31 was embedded into the catalytic pocket of PTP1B. A cellular study found that CYC31 increased the activity of insulin signaling and promoted 2-NBDG uptake through GLUT4 translocation in C2C12 myotubes. Further studies showed that CYC31 ameliorated palmitate-induced insulin resistance in C2C12 myotubes. Moreover, CYC31 treatment significantly increased the mRNA expression of carnitine palmitoyltransferase 1B (CPT-1B) and fatty acid binding protein 3 (FABP3), which was tightly linked with fatty acid oxidation. These findings suggested that CYC31 could prevent palmitate-induce insulin resistance and could improve fatty acid oxidation through PTP1B inhibition. |
format | Online Article Text |
id | pubmed-7281472 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-72814722020-06-17 CYC31, A Natural Bromophenol PTP1B Inhibitor, Activates Insulin Signaling and Improves Long Chain-Fatty Acid Oxidation in C2C12 Myotubes Luo, Jiao Hou, Yufei Xie, Mengyue Ma, Wanli Shi, Dayong Jiang, Bo Mar Drugs Article 3-bromo-4,5-Bis(2,3-dibromo-4,5-dihydroxybenzyl)-1,2-benzenediol (CYC31) is a bromophenol protein tyrosine phosphatase 1B (PTP1B) inhibitor isolated from the red alga Rhodomela confervoides. Here, the effect of CYC31 on the insulin signaling and fatty-acid-induced disorders in C2C12 myotubes was investigated. Molecular docking assay showed that CYC31 was embedded into the catalytic pocket of PTP1B. A cellular study found that CYC31 increased the activity of insulin signaling and promoted 2-NBDG uptake through GLUT4 translocation in C2C12 myotubes. Further studies showed that CYC31 ameliorated palmitate-induced insulin resistance in C2C12 myotubes. Moreover, CYC31 treatment significantly increased the mRNA expression of carnitine palmitoyltransferase 1B (CPT-1B) and fatty acid binding protein 3 (FABP3), which was tightly linked with fatty acid oxidation. These findings suggested that CYC31 could prevent palmitate-induce insulin resistance and could improve fatty acid oxidation through PTP1B inhibition. MDPI 2020-05-19 /pmc/articles/PMC7281472/ /pubmed/32438641 http://dx.doi.org/10.3390/md18050267 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Luo, Jiao Hou, Yufei Xie, Mengyue Ma, Wanli Shi, Dayong Jiang, Bo CYC31, A Natural Bromophenol PTP1B Inhibitor, Activates Insulin Signaling and Improves Long Chain-Fatty Acid Oxidation in C2C12 Myotubes |
title | CYC31, A Natural Bromophenol PTP1B Inhibitor, Activates Insulin Signaling and Improves Long Chain-Fatty Acid Oxidation in C2C12 Myotubes |
title_full | CYC31, A Natural Bromophenol PTP1B Inhibitor, Activates Insulin Signaling and Improves Long Chain-Fatty Acid Oxidation in C2C12 Myotubes |
title_fullStr | CYC31, A Natural Bromophenol PTP1B Inhibitor, Activates Insulin Signaling and Improves Long Chain-Fatty Acid Oxidation in C2C12 Myotubes |
title_full_unstemmed | CYC31, A Natural Bromophenol PTP1B Inhibitor, Activates Insulin Signaling and Improves Long Chain-Fatty Acid Oxidation in C2C12 Myotubes |
title_short | CYC31, A Natural Bromophenol PTP1B Inhibitor, Activates Insulin Signaling and Improves Long Chain-Fatty Acid Oxidation in C2C12 Myotubes |
title_sort | cyc31, a natural bromophenol ptp1b inhibitor, activates insulin signaling and improves long chain-fatty acid oxidation in c2c12 myotubes |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281472/ https://www.ncbi.nlm.nih.gov/pubmed/32438641 http://dx.doi.org/10.3390/md18050267 |
work_keys_str_mv | AT luojiao cyc31anaturalbromophenolptp1binhibitoractivatesinsulinsignalingandimproveslongchainfattyacidoxidationinc2c12myotubes AT houyufei cyc31anaturalbromophenolptp1binhibitoractivatesinsulinsignalingandimproveslongchainfattyacidoxidationinc2c12myotubes AT xiemengyue cyc31anaturalbromophenolptp1binhibitoractivatesinsulinsignalingandimproveslongchainfattyacidoxidationinc2c12myotubes AT mawanli cyc31anaturalbromophenolptp1binhibitoractivatesinsulinsignalingandimproveslongchainfattyacidoxidationinc2c12myotubes AT shidayong cyc31anaturalbromophenolptp1binhibitoractivatesinsulinsignalingandimproveslongchainfattyacidoxidationinc2c12myotubes AT jiangbo cyc31anaturalbromophenolptp1binhibitoractivatesinsulinsignalingandimproveslongchainfattyacidoxidationinc2c12myotubes |